Exagen appoints Scott Kahn to board; three directors resign, board size reduced to 7

EXAGEN INC.

Directors Brian Birk, Wendy Johnson, and Ebetual Pallares to resign effective June 10, 2024; no disagreements cited.
Scott D. Kahn, Ph.D. appointed as Class I director effective June 10, 2024; serves on Compensation and Nominating Committees.
Board size decreases from 9 to 7 members at the effective date.
Dr. Kahn brings 30+ years life sciences experience, including former CIO at Illumina and Chief Information/Privacy Officer at LunaPBC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.